Atopic Dermatitis: Update for Pediatricians

Authors:
  • KGKatherine Grey
    Katherine Grey
  • SMSheilagh Maguiness
    Sheilagh Maguiness

Abstract
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20% of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD.[Pediatr Ann. 2016;45(8):e280–e286.]

This publication has 30 references indexed in Scilit: